Bicara Therapeutics CFO Jennifer Larson files initial beneficial ownership statement
BCAX•Initial Form 3 filed for CFO
Bicara Therapeutics filed an initial Form 3 for CFO Jennifer Larson dated Aug. 12, 2026.
Related News
Iran's deputy foreign minister says won't be intimidated by US threats after Trump's statements on Hormuz
XLE•
Aramark COO Marc Bruno disposes of common shares worth $11.78 million
ARMK•
Integrated Wellness Acquisition delays Q2 10-Q filing, cites more time needed to finalize financial statements
WELNF•
Positron Q2 FY26 net loss narrows to $821,400; revenue falls 6.91% to $111,822
POSC•
Allurion delays quarterly 10-Q filing, seeks extension for June 30 quarter
ALUR•